ArticleJournal of veterinary internal medicine2026
Long-term thyroid outcomes and survival in hyperthyroid cats treated with radioiodine: association with overt and subclinical hypothyroidism and levothyroxine treatment.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-term thyroid status and survival after radioiodine treatment of hyperthyroid cats are incompletely characterized, particularly for cats developing iatrogenic hypothyroidism. HYPOTHESIS/
objectivesTo determine long-term thyroid outcomes and survival after radioiodine treatment, and to assess associations among thyroid status, hypothyroid remission, levothyroxine treatment, and survival. ANIMALS: One thousand three hundred forty-four hyperthyroid cats treated with radioiodine.
methodsProspective longitudinal cohort study. Thyroid and renal status were classified 6-12 months after radioiodine treatment and reassessed at 6- to 12-month intervals until death, euthanasia, relapse, loss to follow-up, or study completion. Kaplan-Meier analysis and Cox proportional hazards regression evaluated survival.
resultsAt 6-12 months, 1047/1344 cats (77.9%) were euthyroid, 240/1344 (17.9%) were subclinically hypothyroid, and 57/1344 (4.2%) were overtly hypothyroid. Among initially euthyroid cats, 934/1047 (89.2%) remained euthyroid, 43 (4.1%) developed late-onset hypothyroidism, and 70 (6.7%) developed recurrent hyperthyroidism. Among initially subclinically hypothyroid cats, 102/240 (42.5%) underwent remission to become euthyroid. Median survival was 49.7 months in euthyroid cats, 44.6 months in subclinically hypothyroid cats, and 36.1 months in overtly hypothyroid cats. In multivariable analysis, initial posttreatment thyroid status was not independently associated with survival, whereas older age, male sex, and higher creatinine concentration were. In final-outcome models, untreated subclinical and overt hypothyroidism were independently associated with an increased hazard of death, whereas hypothyroidism in cats treated with levothyroxine was not. CONCLUSIONS AND CLINICAL IMPORTANCE: Thyroid status after radioiodine treatment is dynamic. Subclinical hypothyroidism frequently resolves, whereas untreated persistent hypothyroidism is associated with shorter survival. Long-term monitoring of thyroid and renal function is critical in managing radioiodine-treated cats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.